sulfinpyrazone has been researched along with 6-ketoprostaglandin f1 alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toivanen, J; Viinikka, L; Ylikorkala, O | 1 |
| Beamish, RE; Dhalla, NS; Karmazyn, M; Moffat, MP | 1 |
2 other study(ies) available for sulfinpyrazone and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphinpyrazone, acetylsalicylic acid and indomethacin by human tissues in vitro.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Epoprostenol; Humans; In Vitro Techniques; Indomethacin; Lung; Sulfinpyrazone; Thromboxane A2; Thromboxane B2 | 1985 |
Comparative effects of acetylsalicylic acid (ASA) and sulfinpyrazone on isoproterenol-induced heart damage.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Urea Nitrogen; Creatine Kinase; Isoproterenol; Male; Myocardial Infarction; Prostaglandins F; Rats; Sulfinpyrazone; Thromboxane B2 | 1981 |